JPS6485915A - Hypotensor - Google Patents

Hypotensor

Info

Publication number
JPS6485915A
JPS6485915A JP62243493A JP24349387A JPS6485915A JP S6485915 A JPS6485915 A JP S6485915A JP 62243493 A JP62243493 A JP 62243493A JP 24349387 A JP24349387 A JP 24349387A JP S6485915 A JPS6485915 A JP S6485915A
Authority
JP
Japan
Prior art keywords
hypotensor
administered
salt
formula
parenteral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP62243493A
Other languages
English (en)
Inventor
Yoshiaki Nakajima
Mamoru Tanaka
Tetsuya Tajima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Priority to JP62243493A priority Critical patent/JPS6485915A/ja
Priority to EP88308448A priority patent/EP0310259B1/en
Priority to DE88308448T priority patent/DE3887426T2/de
Priority to AT88308448T priority patent/ATE100710T1/de
Priority to ES88308448T priority patent/ES2061667T3/es
Priority to CA000577412A priority patent/CA1328613C/en
Priority to US07/248,941 priority patent/US5002958A/en
Priority to DK535388A priority patent/DK535388A/da
Publication of JPS6485915A publication Critical patent/JPS6485915A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Dental Preparations (AREA)
  • Glass Compositions (AREA)
  • Steroid Compounds (AREA)
JP62243493A 1987-09-28 1987-09-28 Hypotensor Pending JPS6485915A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP62243493A JPS6485915A (en) 1987-09-28 1987-09-28 Hypotensor
EP88308448A EP0310259B1 (en) 1987-09-28 1988-09-13 Eperisone as a hypotensive agent
DE88308448T DE3887426T2 (de) 1987-09-28 1988-09-13 Eperisone als Hypotonikum.
AT88308448T ATE100710T1 (de) 1987-09-28 1988-09-13 Eperisone als hypotonikum.
ES88308448T ES2061667T3 (es) 1987-09-28 1988-09-13 Agente hipotensivo para el tratamiento o prevencion de la hipertension.
CA000577412A CA1328613C (en) 1987-09-28 1988-09-14 Hypotensive agent comprising 4' ethyl-2-methyl-3-piperidinopropiophenone
US07/248,941 US5002958A (en) 1987-09-28 1988-09-26 Hypotensive agent
DK535388A DK535388A (da) 1987-09-28 1988-09-27 Anvendelse af piperidinopropiophenonforbindelse til fremstilling af et hypotensivt middel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62243493A JPS6485915A (en) 1987-09-28 1987-09-28 Hypotensor

Publications (1)

Publication Number Publication Date
JPS6485915A true JPS6485915A (en) 1989-03-30

Family

ID=17104710

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62243493A Pending JPS6485915A (en) 1987-09-28 1987-09-28 Hypotensor

Country Status (8)

Country Link
US (1) US5002958A (ja)
EP (1) EP0310259B1 (ja)
JP (1) JPS6485915A (ja)
AT (1) ATE100710T1 (ja)
CA (1) CA1328613C (ja)
DE (1) DE3887426T2 (ja)
DK (1) DK535388A (ja)
ES (1) ES2061667T3 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312778A (en) * 1989-10-03 1994-05-17 Applied Materials, Inc. Method for plasma processing using magnetically enhanced plasma chemical vapor deposition

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010017135A2 (en) * 2008-08-04 2010-02-11 Bionevia Pharmaceuticals, Inc. Novel forms of eperisone
CN102438597A (zh) 2009-03-09 2012-05-02 丁内沙·沙蒂尔阿尔·帕特尔 一种选自中枢性作用肌弛缓药类型的化合物的新型缓释制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075335A (en) * 1972-08-24 1978-02-21 Ciba-Geigy Corporation Pharmaceutical piperidine derivatives
US3995047A (en) * 1973-12-14 1976-11-30 Eisai Co., Ltd. Propiophenone derivatives in the treatment of pathological muscular conditions
GB8422924D0 (en) * 1984-09-11 1984-10-17 Wyeth John & Brother Ltd Prevention of hypertension

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312778A (en) * 1989-10-03 1994-05-17 Applied Materials, Inc. Method for plasma processing using magnetically enhanced plasma chemical vapor deposition

Also Published As

Publication number Publication date
EP0310259A3 (en) 1990-08-22
DE3887426D1 (de) 1994-03-10
US5002958A (en) 1991-03-26
DK535388D0 (da) 1988-09-27
EP0310259B1 (en) 1994-01-26
ES2061667T3 (es) 1994-12-16
CA1328613C (en) 1994-04-19
EP0310259A2 (en) 1989-04-05
ATE100710T1 (de) 1994-02-15
DK535388A (da) 1989-03-29
DE3887426T2 (de) 1994-05-11

Similar Documents

Publication Publication Date Title
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
MX9203543A (es) Medicamento.
ES2001706A6 (es) Procedimiento para la preparacion de derivados peptidicos
SE9002500D0 (sv) Farmaceutisk, nac-innehaallande komposition foer oral administrering
EP0369887A3 (fr) Utilisation de trifluorométhylphényltétrahydropyridines pour la préparation de médicaments destinés à combattre les troubles anxio-dépressifs
DK541189A (da) Anvendelse af nalmefen eller naltrexon til fremstilling af et laegemiddel til behandling af interstitiel cystitis
ES2026304A6 (es) Procedimiento de fabricacion de una forma de dosificacion de nicardipina.
FR2444671A1 (fr) Nouvelles quinazolinones, leur preparation et medicament contenant ces substances
JPS6485915A (en) Hypotensor
ATE47523T1 (de) Pharmazeutische zusammensetzungen.
JPS5767516A (en) Novel analgesic agent
EP0334967A4 (en) Keratosis-treating agent
IL126795A (en) Pharmaceutical compositions for the treatment of substance abuse disorders comprising pyridyl- and pyrimidyl-piperazines
JPS57106618A (en) Anticancer agent consisting of polyprenyl compound
JPS57114512A (en) Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative
ES8603829A1 (es) Procedimiento para la obtencion de nuevos derivados de la piperidina
EP0345883A3 (en) Use of dapiprazole for the manufacture of a pharmaceutical composition inhibiting the development of tolerance in the analgesic treatment with morphine
JPS54132239A (en) Anti-tumor agent
JPS57114519A (en) Antiarteriosclerotic agent
DK623984D0 (da) Farmaceutisk doseringsenhed
JPS57128625A (en) Carcinostatic
JPS57144216A (en) Antiulcer
JPS6357520A (ja) 抗漬瘍剤
EP0308909A3 (en) 1,3-dithiol-2-thiones or 1,3-dithiolane-2-thiones for curing hepatic disease
JPS57114513A (en) Drug against arterioscleriosis comprising (3-dimethylca- rbamoxyphenyl)trimethyl ammonium derivative